We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
In cooperation with Association of Corporate Counsel
  Request new password

Search results

Order by most recent / most popular / relevance

Results: 1-10 of 13

Supreme Court decision in Alice Corp. v. CLS Bank raises more questions than answers

  • LeClairRyan
  • -
  • USA
  • -
  • June 26 2014

The Supreme Court recently issued its much anticipated decision in Alice Corp. v. CLS Bank, unanimously affirming the Federal Circuit's en banc

Supreme Court alters standard for establishing indefiniteness

  • LeClairRyan
  • -
  • USA
  • -
  • June 5 2014

A recent unanimous decision by the U.S. Supreme Court in Nautilus v. Biosig significantly increases the opportunity for a claim to be held as

Between Scylla and Charybdis: future of software patents lies in Supreme Court balance

  • LeClairRyan
  • -
  • USA
  • -
  • April 9 2014

The Supreme Court recently heard oral arguments in Alice Corp. v. CLS Bank, a case in which the outcome may have a dramatic effect on the future and

Isolated, naturally occurring DNA not patent eligible

  • LeClairRyan
  • -
  • USA
  • -
  • June 14 2013

The U.S. Supreme Court ruled on June 13, 2013, in a unanimous opinion, that naturally occurring, isolated DNA is not eligible for patent protection

Patent exhaustion does not apply to planting, harvesting patented plant seeds

  • LeClairRyan
  • -
  • USA
  • -
  • May 16 2013

In Bowman v. Monsanto Co., the U.S. Supreme Court ruled this week that a farmer who buys patented plant seeds may not reproduce them by planting and

Supreme Court invalidates two medical diagnostic methods patents

  • LeClairRyan
  • -
  • USA
  • -
  • March 22 2012

This week, in a unanimous decision, the Supreme Court invalidated claims of two patents relating to medical diagnostic methods, stating that the claims in question amount to nothing more than laws of nature and "well-understood, routine, conventional activity previously engaged in by researchers in the field."

WIPO adds new PCT licensing feature to its PATENTSCOPE website

  • LeClairRyan
  • -
  • Global
  • -
  • January 3 2012

Beginning January 1, 2012, WIPO will launch a new PCT feature whereby applicants interested in licensing inventions contained in their international applications can request the International Bureau to make this information available via its PATENTSCOPE website

Patent reform: Obama signs America Invents Act

  • LeClairRyan
  • -
  • USA
  • -
  • September 16 2011

President Obama today signed into law the America Invents Act, the first significant change in patent law since 1952

U.S. Congress passes sweeping patent reform legislation

  • LeClairRyan
  • -
  • USA
  • -
  • September 8 2011

The U.S. Senate voted today to pass the America Invents Act, a patent reform bill intended to encourage innovation, job creation and economic growth

Federal Circuit rules in favor of Myriad: isolated DNA claims are patent-eligible subject matter

  • LeClairRyan
  • -
  • USA
  • -
  • August 1 2011

On Friday July 29, 2011, the U.S. Court of Appeals for the Federal Circuit ("Federal Circuit") rendered its decision on the appeal by Myriad Genetics, Inc. ("Myriad") of the lower court decision in Ass'n for Molecular Pathology v. U.S. Patent and Trademark Office ("PTO") (No. 2010-1406), which had held that fifteen claims directed to isolated DNA molecules or to methods of use are patent-ineligible under 35 U.S.C. 101